Isolation, identification, and susceptibility testing of <i>Staphylococcus caprae</i> from dairy goats with mastitis to antibiotics and Chinese herbal medicines. [PDF]
Luo J +7 more
europepmc +1 more source
In Silico Insights into the Inhibition of ADAMTS-5 by Punicalagin and Ellagic Acid for the Treatment of Osteoarthritis. [PDF]
Breland AN +3 more
europepmc +1 more source
Comprehensive overview of alternative medicine in the treatment of ankylosing spondylitis: Symptoms, pathogenesis, diagnosis and treatments (Review). [PDF]
Park SY +5 more
europepmc +1 more source
The PGAM5-NEK7 interaction is a therapeutic target for NLRP3 inflammasome activation in colitis. [PDF]
Gao CL +13 more
europepmc +1 more source
Antimicrobial and Anti-Infective Activity of Natural Products: Unveiling Mechanisms, Synergies, and Translational Applications. [PDF]
Fernandes ES +4 more
europepmc +1 more source
Carrier-free self-assembled nanomedicines of active ingredients from pomegranate peel: an overview. [PDF]
Wang M +5 more
europepmc +1 more source
Physiological and Immune Functions of Punicalagin [PDF]
The aim of this publication is to compile a summary of the findings regarding punicalagin in various tissues described thus far in the literature, with an emphasis on the effect of this substance on immune reactions. Punicalagin (PUN) is an ellagitannin found in the peel of pomegranate (Punica granatum).
Adriana Kolesarova +2 more
exaly +4 more sources
Related searches:
Multifaceted Neuroprotective Role of Punicalagin: A Review
Neurochemical Research, 2023Millions of people worldwide are currently afflicted with neurologic conditions like a seizure, depression, stress, Alzheimer's disease, Parkinson's disease, and Huntington's disease. However, the precise etiopathology of these diseases is still unknown. Substantial studies are being conducted to discover more treatments against these disorders because
Nazia, Siddiqui +5 more
openaire +2 more sources
Punicalagin is a neuraminidase inhibitor of influenza viruses
Journal of Medical Virology, 2020AbstractInfluenza A virus (IAV) causes great morbidity and mortality worldwide every year. However, there are only a limited number of drugs clinically available against IAV infection. Further, emergence of drug‐resistant strains can render those drugs ineffective. Thus there is an unmet medical need to develop new anti‐influenza agents. In this study,
Ping, Li +11 more
openaire +2 more sources

